Aivigo is an AI-powered digital musculoskeletal health platform, utilizing computer vision technology to facilitate access to treatment and reduce both direct and indirect costs associated with musculoskeletal issues. Founded in 2022, Aivigo aims to decrease diagnosis, medication, treatment, and surgery costs, as well as the indirect costs such as labor loss and decreased productivity. It provides personalized therapeutic and preventive exercise programs for both patients and healthy users. Aivigo operates within the Health Care industry and has yet to disclose its headquarters, last investment, or the investors involved.
There is no investment information
No recent news or press coverage available for Aivigo.